Intelligent Bio Solutions (INBS) Non-Current Assets (2020 - 2024)
Intelligent Bio Solutions has reported Non-Current Assets over the past 5 years, most recently at $5.5 million for Q1 2024.
- Quarterly results put Non-Current Assets at $5.5 million for Q1 2024, down 11.64% from a year ago — trailing twelve months through Mar 2024 was $5.5 million (down 74.16% YoY), and the annual figure for FY2023 was $6.5 million, up 337.42%.
- Non-Current Assets for Q1 2024 was $5.5 million at Intelligent Bio Solutions, down from $5.9 million in the prior quarter.
- Over the last five years, Non-Current Assets for INBS hit a ceiling of $11.7 million in Q4 2022 and a floor of $135692.0 in Q2 2020.
- Median Non-Current Assets over the past 5 years was $3.4 million (2021), compared with a mean of $4.0 million.
- Biggest five-year swings in Non-Current Assets: surged 2591.63% in 2021 and later tumbled 59.36% in 2022.
- Intelligent Bio Solutions' Non-Current Assets stood at $135692.0 in 2020, then skyrocketed by 748.24% to $1.2 million in 2021, then soared by 913.9% to $11.7 million in 2022, then crashed by 49.59% to $5.9 million in 2023, then fell by 6.19% to $5.5 million in 2024.
- The last three reported values for Non-Current Assets were $5.5 million (Q1 2024), $5.9 million (Q4 2023), and $6.0 million (Q3 2023) per Business Quant data.